{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:04:12Z","timestamp":1784761452423,"version":"3.55.0"},"reference-count":46,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,6,4]],"date-time":"2003-06-04T00:00:00Z","timestamp":1054684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>In the United States, incidence rates for malignant tumors of the uterine corpus are lower among blacks than among whites, whereas mortality rates are higher among blacks. Reasons for the higher level of mortality among blacks have been debated.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Using data from the Surveillance, Epidemiology, and End Results program, the authors compared incidence rates by histopathologic type for malignant tumors of the uterine corpus (including uterus, not otherwise specified) during the period 1992\u20131998 among white Hispanic, black, and white non\u2010Hispanic patients. The authors also compared cumulative relative survival rates for blacks and whites by histopathologic type and by other factors, and they calculated estimated type\u2010specific mortality rates.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Overall incidence (per 100,000 woman\u2010years) of corpus malignancy was significantly lower among white Hispanics (14.04; 95% confidence interval [CI], 13.39\u201314.72) and blacks (15.31; 95% CI, 14.61\u201316.04) compared with white non\u2010Hispanics (23.43; 95% CI, 23.06\u201323.81). Compared with white non\u2010Hispanics, blacks had significantly higher incidence rates of serous\/clear cell carcinoma (rate ratio, 1.85; 95% CI, 1.61\u20132.12), carcinosarcoma (rate ratio, 2.33; 95% CI, 1.99\u20132.72), and sarcoma (rate ratio, 1.56; 95% CI, 1.31\u20131.86). Survival was worse for blacks than for whites in every histopathologic category and in \u2018usual\u2019 types of endometrial adenocarcinoma, stratified by stage, grade, and age. Rare aggressive tumor types accounted for 53% of mortality among blacks, compared with 36% among whites.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Less favorable outcomes for usual types of endometrial adenocarcinoma and for rare aggressive tumors contribute equally to the relatively high mortality due to corpus cancer among black women. Cancer 2003;98:176\u201386. Published 2003 by the American Cancer Society.*<\/jats:p><jats:p>DOI 10.1002\/cncr.11484<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.11484","type":"journal-article","created":{"date-parts":[[2003,6,23]],"date-time":"2003-06-23T12:15:02Z","timestamp":1056370502000},"page":"176-186","source":"Crossref","is-referenced-by-count":194,"title":["Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus"],"prefix":"10.1002","volume":"98","author":[{"given":"Mark E.","family":"Sherman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Devesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,6,4]]},"reference":[{"key":"e_1_2_6_2_2","volume-title":"Cancer epidemiology and prevention","author":"Grady D","year":"1996"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.52.1.23"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2106"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880051"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90240-V"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(87)80089-3"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90261-9"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2629::AID-CNCR30>3.0.CO;2-2"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(96)00341-9"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(95)80002-6"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1546::AID-CNCR9>3.0.CO;2-M"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1997.4617"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/oxfordjournals.aje.a115942","article-title":"Black\u2010white differences in stage\u2010specific cancer survival: analysis of seven selected sites","volume":"133","author":"Ragland KE","year":"1991","journal-title":"Am J Epidemiol"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/oxfordjournals.aje.a114373","article-title":"Factors associated with survival differences between black women and white women with cancer of the uterine corpus","volume":"124","author":"Steinhorn SC","year":"1986","journal-title":"Am J Epidemiol."},{"key":"e_1_2_6_16_2","first-page":"134","article-title":"Racial differences in surgically staged patients with endometrial cancer","volume":"89","author":"Hicks ML","year":"1997","journal-title":"J Natl Med Assoc."},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.4594"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(83)90111-7"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198203000-00002"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/73.2.341"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00052938"},{"key":"e_1_2_6_22_2","first-page":"399","article-title":"The epidemiology of sarcomas of the uterus","volume":"76","author":"Harlow BL","year":"1986","journal-title":"J Natl Cancer Inst."},{"key":"e_1_2_6_23_2","volume-title":"SEER cancer statistics review: 1973\u20131998","author":"Ries LA","year":"2001"},{"key":"e_1_2_6_24_2","volume-title":"International classification of diseases for oncology","author":"Percy C","year":"1990"},{"key":"e_1_2_6_25_2","unstructured":"SEER*STAT [software online]2001. Available from URL:http:\/\/seer.cancer.gov\/seerstat"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(94)90089-2"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199206000-00008"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(01)01447-8"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.15.1019"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.1997.6.309"},{"key":"e_1_2_6_31_2","first-page":"1","article-title":"Hysterectomy surveillance\u2014United States, 1980\u20131993","volume":"46","author":"Lepine LA","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009142"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0800541"},{"key":"e_1_2_6_34_2","first-page":"89","article-title":"Surveillance for five health risks among older adults\u2014United States, 1993\u20131997","volume":"48","author":"Kamimoto LA","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-2797(97)00207-X"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/153.9.865"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116675"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910540214"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.6.1241"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.2307\/2135493"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.16.1127"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1704"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(00)01723-4"},{"key":"e_1_2_6_44_2","first-page":"963","article-title":"Analysis of risk factors and hormone levels in patients with uterine serous carcinoma","volume":"10","author":"Sherman ME","year":"1997","journal-title":"Mod Pathol."},{"key":"e_1_2_6_45_2","first-page":"187","article-title":"Familial and hormonal risk factors for papillary serous uterine cancer","volume":"23","author":"Elit L","year":"2002","journal-title":"Eur J Gynaecol Oncol."},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910490308"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.4941"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.11484","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.11484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T14:25:53Z","timestamp":1760279153000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.11484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,4]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1002\/cncr.11484"],"URL":"https:\/\/doi.org\/10.1002\/cncr.11484","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,4]]}}}